Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of …

… treated patients with transcriptionally addicted solid tumors SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) — Kronos.